{
    "fund_name": "WisdomTree Long JPY Short EUR 3x Daily",
    "type": "ETP",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x daily leverage",
        "Inverse exposure",
        "Synthetic replication via FX forwards",
        "High risk profile (7/7)",
        "Daily compounding effect",
        "Complex index tracking (MSFXSM Triple Long Japanese Yen/Euro Total Return Index)",
        "Counterparty risk from derivative exposure"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex due to multiple MiFID II complexity indicators: 1) 3x daily leverage creates significant volatility and compounding effects that make performance unpredictable over longer periods; 2) Synthetic replication via FX forwards introduces counterparty risk; 3) Inverse exposure mechanism increases complexity; 4) The product is designed for short-term trading (1-day recommended holding period) which is inherently complex for retail investors; 5) The risk profile is rated 7/7 (highest risk level); 6) The product uses derivatives as an inherent part of its strategy rather than for efficient portfolio management. While the product is UCITS-eligible, the combination of these factors clearly places it in the complex category. The PRIIPs KID would likely contain a comprehension warning, further supporting this classification.",
    "confidence": 95,
    "counter_arguments": "One might argue that since the product is UCITS-eligible and fully collateralized, it should be considered non-complex. However, UCITS eligibility doesn't automatically make a product simple - the combination of 3x leverage, inverse exposure, and synthetic replication with daily compounding effects creates a product that requires specialist knowledge to understand, which is the key determinant of complexity under MiFID II.",
    "risk_level": "7/7 (highest risk)",
    "alignment_with_risk_profile": "The complex classification aligns perfectly with the stated risk profile of 7/7, as the product's features (leverage, inverse exposure, synthetic replication) all contribute to this high-risk assessment."
}